Cite
HARVARD Citation
Mancini, M. et al. (2018). An oligoclonal antibody durably overcomes resistance of lung cancer to third‐generation EGFR inhibitors. EMBO molecular medicine. 10 (2), pp. 294-308. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mancini, M. et al. (2018). An oligoclonal antibody durably overcomes resistance of lung cancer to third‐generation EGFR inhibitors. EMBO molecular medicine. 10 (2), pp. 294-308. [Online].